General Information
Product name
Sildenafil Tablets, USP : 25 mg, 50 mg and 100 mg
Chemical name
Therapeutic Category
CAS No.
171599-83-0
1.2.1 Relevant identified uses
Treatment of Erectile dysfunction
Icons in SDS
Company Information
company name
Ajanta Pharma USA Inc
Section 2
Health hazards
information
Potential health effects
Inhalation Not expected to be hazardous in final pharmaceutical form. Eye Contact Not expected to be hazardous in final pharmaceutical form. Skin Contact Not expected to be hazardous in final pharmaceutical form. Ingestion Health injuries are not known or expected under normal use. Exposures above clinical dosage could result in adverse effects. Minor occupational exposures are not expected to be harmful Effects of Overexposure : The potential for exposure is reduced in finished pharmaceutical dosage form.